Cleared Special

K101196 - ACCU-CHEK ULTRFLEX INFUSION SET

K101196 is an FDA 510(k) clearance for ACCU-CHEK ULTRFLEX INFUSION SET, manufactured by Roche Diagnostics Corp.. The device is a Class 2 General Hospital device with product code FPA cleared through the Special 510(k) pathway after a 120-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2010
Decision
120d
Days
Class 2
Risk

K101196 is an FDA 510(k) clearance for the ACCU-CHEK ULTRFLEX INFUSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on August 27, 2010 after a review of 120 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K101196

510(k) Number K101196 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 29, 2010
Decision Date August 27, 2010
Days to Decision 120 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 129d · This submission: 120d
Pathway characteristics
Modification to existing cleared device.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 984
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K101196.
MED-RX TRANSFER SET, MODELS 10-1227TS, 10-1300TS, 10-1305TS AND 10-1306TS
K102073 · Benlan, Inc. · Nov 2010
K-SHIELD SMALL VEIN INFUSION / WINGED COLLECTION SET W/ ANTI NEEDLE STICK PROTECTOR (AND MULTISAMPLE LUER ADAPTER)
K102890 · Kawasumi Laboratories America, Inc. · Oct 2010
AMSINO I.V. ADMINISTRATION AND EXTENSION SETS
K101958 · Amsino International, Inc. · Sep 2010
HOSPIRA INFUSION BLOOD SETS
K101677 · Hospira, Inc. · Aug 2010
GRIPPER MICRO BLUNT CANNULA, NON-CORING SAFETY NEEDLE (GRIPPER MICRO NEEDLE) MODEL: 21-3253-24, 21-3258-24, 21-3262-24,
K101180 · Smiths Medical MD, Inc. · Aug 2010
INTRAVSCULAR ADMINISTRATION SET
K100946 · Terumo Europe N.V. · Aug 2010